Framework
The 38% Series C Survival Rate
Of every US company that completed a Series C between 2010 and 2015, only 38% had produced value for employee shareholders a decade later. Yet investing in all of them would have generated over 5x returns. Concentration in a single company exposes you to the 62% failure scenario. Diversification across the cohort captures the portfolio return.
How it works
- 1The data: cohort of all US Series C financings from 2010-2015, analyzed a decade later - 62% had not produced value for employee shareholders, regardless of the growth trajectory at the time of the Series C close
- 2The portfolio paradox: the same cohort, invested across all companies, returned over 5x - the failure rate of individual companies is not incompatible with strong portfolio returns; concentration is what converts individual failure risk into personal financial disaster
- 3The founder psychology trap: every CEO who closes a Series C believes the sky is the limit - and statistically, they should feel that way, because the company is genuinely promising. But every other CEO in the 62% felt the same way. The Series C is not a signal that the outcome is secure
- 4The binary outcome problem: venture equity creates an all-or-nothing structure for employees - either the company exits well or the decade of equity accumulation produces nothing. Diversification converts the binary outcome into a portfolio return that captures upside across the cohort
- 5The time dimension: a three or four year venture-to-exit timeline meant binary outcomes were short-term bets. A ten to fifteen year private company lifecycle means the binary outcome is a major life event - a decade of career investment with no hedge
- 6The practical implication: Greg's typical recommendation is not to exchange everything, but to exchange 15-20% and create a floor. The remaining 80-85% still participates in the upside if the company is in the 38%; the 15-20% ensures some wealth creation even if it is in the 62%
Hear it on the podcast
Turn Illiquid Equity Into Real WealthListen to the episodeMore from this episode
The Private Market Exchange Fund ModelExchange illiquid single-company shares for a diversified LP interest in a pooled fund - tax-free. The compounding of deferred taxes generates approximately 2x the after-tax wealth over seven years compared to a taxable sale and reinvestment. For a decade-long startup journey, the difference between a tax event at year five and no tax event can define the outcome.The Private Market Liquidity GapThe private secondary market turns over approximately 3-4% of its $4 trillion asset base annually. Public small-cap indices turn over 100% per year. The gap between actual and potential liquidity is not a reflection of supply constraints - it reflects how early the infrastructure build is. Greg's frame: if the market matures toward public market norms, the growth ahead dwarfs everything that has happened so far.
Get the next framework first
One email a week with the frameworks, tools, and founder stories from the podcast. Free.
More frameworks for Fundraising & Money
Two-Barrier Framework for Alternative InvestmentsCJ Follini's diagnosis of why individual investors stay out of alternative assets despite their superior risk-adjusted returns: two structural barriers — due diligence complexity and illiquidity. Both are planning problems, not knowledge problems. Neither can be solved without first building 2–3 years of personal budgeting history that reveals true investible cash, liquidity timeline, and risk tolerance.Yale Endowment Model for IndividualsDavid Swensen's Modern Portfolio Theory applied at scale: diversify across uncorrelated asset classes with 25%+ allocation to alternatives (real estate, private equity, venture capital, fine art, natural resources). The conventional 60/40 portfolio optimizes for mediocrity. Swensen optimized for risk-adjusted returns — and ran Yale's endowment at #1 for 20 consecutive years. CJ Follini spent 35 years applying this for ultra-high-net-worth families; Noyack's Profit AI democratizes it for individuals.Outcome-Aligned Revenue ModelAxenya's approach to incentive alignment: charge a performance fee on the measurable delta between a client's healthcare cost growth and the market baseline. No outcome, no fee — making the vendor's financial interest structurally identical to the client's health interest.The Three-Bucket Expense ModelSeparate every business expense into Fixed (operating costs), Variable (sales-related costs), and Advertising (fuel). Treating advertising as a lever — not overhead — gives founders real-time control over the one expense category they can actually dial up or down.The Profit Foundation First FrameworkSet how much you should be spending on fixed and variable costs before touching advertising. ROAS is a vanity metric without knowing your true cost structure — high ROAS can coexist with losing money every month.The Bootstrap-Before-VC Stress TestBefore you chase a check, sit with this: if you bootstrapped to $500K ARR and kept 100% of your company, would you actually be worse off than taking that seed round?